Colin Downey Selected Research

Colin Downey Research Topics

7	Sepsis (Septicemia) 01/2020 - 01/2003
5	Critical Illness (Critically Ill) 01/2021 - 12/2002
4	Disseminated Intravascular Coagulation 11/2005 - 10/2002
3	Inflammation (Inflammations) 08/2013 - 11/2005
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Infections 01/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2013
1	Cerebral Malaria 08/2013
1	Thrombosis (Thrombus) 08/2013
1	Hypocalcemia 06/2013
1	Disease Progression 06/2013
1	Meningococcal Infections 11/2011

7	C-Reactive ProteinIBA 01/2021 - 10/2002
4	Protein CIBA 08/2013 - 02/2005
4	Dacarbazine (DIC)FDA LinkGeneric 11/2005 - 10/2002
3	ProcalcitoninIBA 01/2021 - 11/2011
3	VLDL LipoproteinsIBA 01/2020 - 10/2002
3	Endothelial Protein C ReceptorIBA 08/2013 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2013
2	AnticoagulantsIBA 08/2013 - 03/2009
2	CalciumIBA 06/2013 - 03/2004
2	Lipoproteins (Lipoprotein)IBA 01/2003 - 12/2002
1	ResistinIBA 01/2021
1	Lipocalin-2IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	FibrinIBA 12/2013
1	formycin diphosphate (FDP)IBA 12/2013
1	fibrin fragment D (D-dimer)IBA 12/2013
1	Antithrombin IIIIBA 12/2013
1	fibrinmonomerIBA 12/2013
1	Fibrin Fibrinogen Degradation ProductsIBA 12/2013
1	Fibrinogen (Factor I)FDA Link 12/2013
1	Indicators and Reagents (Reagents)IBA 12/2013
1	ThrombomodulinIBA 08/2013
1	ElectrolytesIBA 06/2013
1	SodiumIBA 06/2013
1	MagnesiumIBA 06/2013
1	AlbuminsIBA 06/2013
1	drotrecogin alfa activated (Xigris)FDA Link 08/2011
1	PAR-1 ReceptorIBA 03/2009
1	Thromboplastin (Tissue Factor)IBA 03/2004
1	VLDL CholesterolIBA 12/2002

1	Therapeutics 01/2020
1	Critical Care (Surgical Intensive Care) 08/2011